Expanding What’s Possible: A Practical Guide for Lab Growth
The future of clinical laboratory growth isn’t defined by how many tests a lab performs. In this post, we discuss what’s essential for labs to scale.
Category: Company News
Discover the latest news and updates from Immundiagnostik, Inc.
5 Questions Every Clinical Lab Leader Should Ask Before Adding a New Assay
Adding a new assay creates opportunity. It also creates operational responsibility. Before expanding your test menu, take a strategic step back and ask yourself these crucial questions.
Why Clinical Labs Need More Than Assays and Detection Tools
High-quality assays are only one piece of a successful lab strategy. In this blog, we unpack why the strongest partnerships begin long before a purchase order.
Beyond Diagnostics: How Lab Medicine Is Evolving Toward Health Intelligence
Healthcare is evolving, and with it, the role of the clinical laboratory. In this post, we discuss how labs can prepare for what’s next.
How Fecal Gluten Peptide Testing Can Help Assess Gluten-Free Diet Adherence
This Q&A reviews how stool-based gluten peptide testing may support clinical evaluation, dietary counseling, and conversations about unintended exposure.
Celiac Disease and Women’s Health: What Emerging Research is Revealing
Women are diagnosed with celiac disease two to three times more often than men. New studies are now exploring why celiac disease shows different immunological and physiological effects in women.
Immundiagnostik and Diagnostic Solutions Laboratory to Highlight Fecal Gluten Peptide Testing at DDW 2026
Visit IDK, Inc. and DSL at DDW 2026 to discover a new way to monitor adherence to a gluten-free diet and assess gluten exposure in celiac disease and non-celiac gluten sensitivity.
Tools to Investigate the Microbiome-Gut-Brain Axis in IBS
Discover how investigating neurotransmitters can provide a deeper understanding of the microbiome-gut-brain axis in IBS.